TP53 and neoplasm: All clinical and pathological data of the patients were complete, including age, tumor size, axillary lymph node status, LVI status, histological grade, pathological type, ER/PR/HER2/Ki67/P53 status, and surgical and postoperative adjuvant treatment (specified as chemotherapy, targeted therapy, radiotherapy, and endocrine therapy).